Evidence map›Paper›PMID 39138783›Full record

ArticleIrish journal of medical science2024

Association between JAK2

Ryan Brown, Joanna Jasiakiewicz, Victoria Greer, Andrew Hindley, Katie McDowell, Eadaoin Devlin, Kathryn Clarke, Frances Buckley, Clare Crean, Julie McGimpsey and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Irish journal of medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. The impact of JAK2British journal of haematology · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ryan BrownHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Joanna JasiakiewiczHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Victoria GreerHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Andrew HindleyHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Katie McDowellHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Eadaoin DevlinHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Kathryn ClarkeHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Frances BuckleyHaematology Department, NHS Highland, Inverness, Scotland, UK.
Clare CreanHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Julie McGimpseyHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Robert J G CuthbertHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Nick CunninghamHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Claire ArnoldHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Damian FinneganHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Gary BensonHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.
Mary Frances McMullinHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK. M.McMullin@qub.ac.uk.
Mark A CatherwoodHaematology, Belfast City Hospital, BHSCT, Belfast, Northern Ireland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyeloproliferative neoplasms (MPNs) are a group of chronic disorders of the bone marrow characterised by the overproduction of clonal myeloid stem cells. The most common driver mutation found in MPNs is a point mutation on exon 14 of the JAK2 gene, JAK2

aimsThe aim of this study was to determine if JAK2

methodsJAK2

resultsWe observed a significantly higher JAK2

conclusionsWe have shown that a higher JAK2

Indexed as

Gene FrequencyJanus Kinase 2Myeloproliferative DisordersThrombosisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRisk FactorsJAK2 protein, humanJanus Kinase 2JAK2Myeloproliferative neoplasmThrombosisVariable allele frequency

Identifiers

PMID39138783
PMCPMC11666684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.